Contract award
AN2 THERAPEUTICS, INC
DEVELOPMENT OF EPETRABOROLE AS A NOVEL THERAPEUTIC FOR MELIOIDOSIS AND ADDITIONAL ANTIMICROBIAL RESISTANT (AMR) BACTERIAL BIOTHREAT PATHOGENS.
- PIID
- 75N93022C00059
- Award key
- CONT_AWD_75N93022C00059_7529_-NONE-_-NONE-
- Recipient UEI
- DD4FE2GE4L78
- Source as of
- —
Current award value
$9,235,5773
Obligated to date
$9,235,5772
Potential with options
$18,274,7783
- Awarding agency
- Department of Health and Human ServicesNational Institutes of Health
- Contractor
- AN2 THERAPEUTICS, INC
- Place of performance
- Menlo Park, California
- Set-aside
- No set-aside used
- Pricing
- Cost No Fee
- Competition
- Full and Open Competition30 offers received
- Period of performance
- Sep 20, 2022 — Jul 31, 2027Through Jul 31, 2027 if all options are exercised
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | Sep 20, 2022 | Initial award | $4,306,405.00 | $9,235,577.00 |
| P00001 | Apr 12, 2023 | B | $0.00 | $9,235,577.00 |
| P00002 | Jul 11, 2023 | G | $651,041.00 | $9,235,577.00 |
| P00003 | Mar 1, 2024 | B | $0.00 | $9,235,577.00 |
| P00004 | May 14, 2024 | G | $3,821,365.00 | $9,235,577.00 |
| P00005 | Jul 31, 2024 | B | $0.00 | $9,235,577.00 |
| P00006 | Sep 27, 2024 | B | $0.00 | $9,235,577.00 |
| P00007 | Dec 20, 2024 | B | $0.00 | $9,235,577.00 |
| P00008 | Apr 28, 2025 | B | $456,766.00 | $9,235,577.00 |
| P00009 | Nov 26, 2025 | B | $0.00 | $9,235,577.00 |
| P00010 | Apr 24, 2026 | B | $0.00 | $9,235,577.00 |
| P00011 | Aug 18, 2026 | B | $0.00 | $9,235,577.00 |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | — | Aug 20, 2026 | usaspending_contract_csv@2026.08.2 | 93904f1b58f9 |
| contractor_id | USAspending.gov | — | Aug 20, 2026 | usaspending_contract_csv@2026.08.2 | 93904f1b58f9 |
| current_award_value | USAspending.gov | — | Aug 20, 2026 | usaspending_contract_csv@2026.08.2 | 93904f1b58f9 |
| naics_code | USAspending.gov | — | Aug 20, 2026 | usaspending_contract_csv@2026.08.2 | 93904f1b58f9 |
| potential_award_value | USAspending.gov | — | Aug 20, 2026 | usaspending_contract_csv@2026.08.2 | 93904f1b58f9 |
| psc_code | USAspending.gov | — | Aug 20, 2026 | usaspending_contract_csv@2026.08.2 | 93904f1b58f9 |
| total_obligated | USAspending.gov | — | Aug 20, 2026 | usaspending_contract_csv@2026.08.2 | 93904f1b58f9 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 12 transaction records parsed from USAspending.gov, retrieved Aug 20, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.